{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:12:41Z","timestamp":1793610761885,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973271"],"award-info":[{"award-number":["81973271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijpharm.2022.122467","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T16:43:28Z","timestamp":1670431408000},"page":"122467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Persistent immune response: Twice tumor exfoliation induced by sialic acid\u2013modified vincristine sulfate liposomes"],"prefix":"10.1016","volume":"631","author":[{"given":"Xinyang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2022.122467_b0005","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/JVI.00037-14","article-title":"Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-\u03baB activation through TBK1","volume":"88","author":"Abe","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.yexcr.2010.11.013","article-title":"Chemokines in cancer related inflammation","volume":"317","author":"Allavena","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijpharm.2022.122467_b0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","article-title":"The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling","volume":"54","author":"Cai","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijpharm.2022.122467_b0020","first-page":"S86","article-title":"Antivascular approaches to solid tumour therapy: evaluation of tubulin binding agents","volume":"27","author":"Chaplin","year":"1996","journal-title":"Br. J. Can. Suppl."},{"key":"10.1016\/j.ijpharm.2022.122467_b0025","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijpharm.2022.122467_b0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","article-title":"Siglecs as immune cell checkpoints in disease","volume":"38","author":"Duan","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0040","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.bbamem.2006.05.028","article-title":"Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient","volume":"1758","author":"Fritze","year":"2006","journal-title":"BBA"},{"key":"10.1016\/j.ijpharm.2022.122467_b0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/exd.13417","article-title":"Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages","volume":"27","author":"Fujimura","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2022.122467_b0055","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2184.1992.tb01457.x","article-title":"Cell death induced by vincristine in the intestinal crypts of mice and in a human Burkitt's lymphoma cell line","volume":"25","author":"Harmon","year":"1992","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijpharm.2022.122467_b0060","first-page":"417","article-title":"In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton","volume":"21","author":"Hayot","year":"2002","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10549-021-06369-3","article-title":"Classes of therapeutics to amplify the immune response","volume":"191","author":"Hu","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijpharm.2022.122467_b0070","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2022.122467_b0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12967-020-02618-z","article-title":"Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients","volume":"18","author":"Hwang","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijpharm.2022.122467_b0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.21037\/atm-20-3735","article-title":"Future of immune checkpoint inhibitors: focus on tumor immune microenvironment","volume":"8","author":"Jia","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ijpharm.2022.122467_b0085","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1073\/pnas.1219888110","article-title":"Targeted delivery of lipid antigen to macrophages via the CD169\/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation","volume":"110","author":"Kawasaki","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.ijpharm.2022.122467_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2736(98)00175-8","article-title":"Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient","volume":"1415","author":"Li","year":"1998","journal-title":"BBA"},{"key":"10.1016\/j.ijpharm.2022.122467_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","article-title":"Harnessing tumor-associated macrophages as aids for cancer immunotherapy","volume":"18","author":"Li","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpharm.2022.122467_b0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2021.06.027","article-title":"Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy","volume":"337","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122467_b0105","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2022.122467_b0110","doi-asserted-by":"crossref","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2022.122467_b0115","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acs.molpharmaceut.9b00770","article-title":"Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122467_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121415","article-title":"Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy","volume":"283","author":"Liu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2022.122467_b0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/scbi.2001.0398","article-title":"Tumor cell recognition by natural killer cells","volume":"12","author":"Long","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0130","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2018.06.021","article-title":"Targeted delivery of pixantrone to neutrophils by poly(sialic acid)-p-octadecylamine conjugate modified liposomes with improved antitumor activity","volume":"547","author":"Luo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122467_b0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijpharm.2022.122467_b0140","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2147\/IJN.S205276","article-title":"Development of a stable single-vial liposomal formulation for vincristine","volume":"14","author":"Mao","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2022.122467_b0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coi.2016.12.003","article-title":"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis","volume":"45","author":"M\u00e9ndez-Huergo","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2015.08.026","article-title":"Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma","volume":"216","author":"Nakamura","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122467_b0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijpharm.2022.122467_b0160","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1172\/JCI71389","article-title":"Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain","volume":"124","author":"Old","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2022.122467_b0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijpharm.2022.122467_b0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2022.122467_b0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41419-020-2567-0","article-title":"Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment","volume":"11","author":"Serpico","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijpharm.2022.122467_b0180","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.biomaterials.2014.03.022","article-title":"The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate","volume":"35","author":"She","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2022.122467_b0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijpharm.2022.122467_b0190","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2022.122467_b0200","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/1074-7613(94)90044-2","article-title":"Generation and in vivo persistence of polarized Th1 and Th2 memory cells","volume":"1","author":"Swain","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.ijpharm.2022.122467_b0205","first-page":"59","article-title":"Helper T cell memory: more questions than answers","volume":"4","author":"Swain","year":"1992","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0210","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-09-1106","article-title":"Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation","volume":"69","author":"Tanaka","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2022.122467_b0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","article-title":"Galectins and immune responses-just how do they do those things they do?","volume":"34","author":"Thiemann","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0220","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ni1482","article-title":"Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death","volume":"8","author":"Toscano","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0225","doi-asserted-by":"crossref","first-page":"1r","DOI":"10.1093\/glycob\/cwj008","article-title":"Siglecs\u2013the major subfamily of I-type lectins","volume":"16","author":"Varki","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijpharm.2022.122467_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0235","article-title":"Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing","volume":"11","author":"Vyacheslav","year":"2006","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.ijpharm.2022.122467_b0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.08.028","article-title":"Immunogenic cell death in anticancer chemotherapy and its impact on clinical studies","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpharm.2022.122467_b0245","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ijpharm.2022.122467_b0250","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.it.2015.02.003","article-title":"The STING pathway and the T cell-inflamed tumor microenvironment","volume":"36","author":"Woo","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijpharm.2022.122467_b0255","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2022.122467_b0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-genet-112414-054842","article-title":"The ecology and evolution of cancer: the ultra-microevolutionary process","volume":"50","author":"Wu","year":"2016","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.ijpharm.2022.122467_b0265","unstructured":"Zhao Y. Study on Vincristine Sulfate Liposomes, Shenyang Pharmaceutical University. 2005."},{"key":"10.1016\/j.ijpharm.2022.122467_b0270","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jconrel.2005.10.011","article-title":"Formation of drug-arylsulfonate complexes inside liposomes: a novel approach to improve drug retention","volume":"110","author":"Zhigaltsev","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2022.122467_b0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2017.03.034","article-title":"Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity","volume":"523","author":"Zhou","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2022.122467_b0280","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Can."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517322010225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517322010225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T20:08:57Z","timestamp":1729627737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517322010225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":56,"alternative-id":["S0378517322010225"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122467","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent immune response: Twice tumor exfoliation induced by sialic acid\u2013modified vincristine sulfate liposomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122467"}}